Tiffany R. Keepers, Ph.D.
Affiliations: | 2007 | University of Virginia, Charlottesville, VA |
Area:
Microbiology BiologyGoogle:
"Tiffany Keepers"Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Obata F, Tohyama K, Bonev AD, et al. (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. The Journal of Infectious Diseases. 198: 1398-406 |
| Roche JK, Keepers TR, Gross LK, et al. (2007) CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. The American Journal of Pathology. 170: 526-37 |
| Keepers TR, Gross LK, Obrig TG. (2007) Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infection and Immunity. 75: 1229-36 |
| Keepers TR, Psotka MA, Gross LK, et al. (2006) A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. Journal of the American Society of Nephrology : Jasn. 17: 3404-14 |
| Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, et al. (2005) Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function. Thrombosis and Haemostasis. 94: 1019-27 |
| Houpt ER, Glembocki DJ, Obrig TG, et al. (2002) The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 4496-503 |